^○Mitsuharu Ueda¹, David Adams², Alejandra González-duarte³, Elizabeth A Mauricio⁴, Thomas H Brannagan⁵, Teresa Coelho⁶, Jonas Wixner⁷, Hartmut Schmidt⁸, Erhan Berber⁹, Marianne Sweetser⁹, Matthew T White⁹, Jing Jing Wang⁹, Michael Polydefkis¹⁰ (1.Department of Neurology, Kumamoto University Hospital, Japan, 2.National Reference Center for FAP (NNERF)/ APHP/ INSERM U 1195/ CHU Bicêtre, Le Kremlin Bicêtre, France, 3.Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico, 4.Mayo Clinic, Jacksonville, FL, USA, 5.Department of Neurology, Columbia University, New York City, NY, USA, 6.Centro Hospitalar Universitário do Porto, Portugal, 7.Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden, 8.University Hospital Muenster, Muenster, Germany, 9.Alnylam Pharmaceuticals, Cambridge, USA, 10.Johns Hopkins University, Baltimore, USA)

^○Youwei Lin¹, Narita Tomoko², Satoru Oji³, Katsuichi Miyamoto⁴, Hiroshi Takashima⁵, Kimiaki Utsugisawa⁶, Masaaki Niino⁷, Kazumasa Yokoyama⁸, Osamu Watanabe⁹, Shugo Suwazono¹⁰, Masahiro Mori¹¹, Hiroo Yoshikawa¹², Hidenori Matsuo¹³ (1.Dep.Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Dep.Neurology, Nagasaki Kawatana Medical Center, 3.Dep.Neurology, Saitama Medical Center, 4.Dep.Neurology, Kindai University Hospital, 5.Dep.Neurology and Geriatrics, Kagoshima University Hospital, 6.Dep.Neurology, General Hanamaki Hospital, 7.Dep.Neurology, Hokkaido Medical Center, 8.Dep.Neurology, Juntendo University Hospita, 9.Dep.Neurology, Kagoshima City Hospital, 10.Dep.Neurology, Okinawa National Hospital, 11.Dep.Neurology, Chiba University Hospital, 12.Dep. Neurology, Hyogo College of Medicine Hospital, 13.Nagasaki National Hospital)

^○Kanta Tanaka^1,2, Masatoshi Koga¹, Keon-joo Lee³, Beom Joon Kim³, Eun Lyeong Park⁴, Juneyoung Lee⁴, Tadataka Mizoguchi¹, Sohei Yoshimura¹, Jae-kwan Cha⁵, Byung-chul Lee⁶, Jin Nakahara², Norihiro Suzuki², Kazunori Toyoda^1,2 (1.National Cerebral and Cardiovascular Center, Japan, 2.Keio University, Japan, 3.Seoul National University Bundang Hospital, 4.Korea University, 5.Dong-A University Hospital, 6.Hallym University Sacred Heart Hospital)

^○Anthony Traboulsee¹, Benjamin Greenberg², Jeffrey L. Bennett³, Lech Szczechowski⁴, Edward Fox⁵, Svitlana Shkrobot⁶, Takashi Yamamura⁷, Yusuke Terada⁸, Yuichi Kawata⁸, Pádraig Wright⁹, H.-christian Von Büdingen¹⁰, Gaelle Klingelschmitt¹⁰, Athos Gianella-borradori¹¹, Brian G. Weinshenker¹² (1.University of British Columbia, Canada, 2.University of Texas Southwestern Medical Center, 3.University of Colorado School of Medicine, 4.Silesian Centre of Neurology, 5.Central Texas Neurology Consultants, 6.Ternopil State Medical University, 7.National Center of Neurology and Psychiatry, 8.Chugai Pharmaceutical Co., Ltd, Tokyo, 9.Chugai Pharma Europe Ltd. London, 10.F. Hoffmann-La Roche Ltd, 11.Chugai Pharma USA LLC, 12.Mayo Clinic)

^○Ichiro Nakashima¹, Kazuo Fujihara^2,3, Achim Berthele⁴, Ho Jin Kim⁵, Michael Levy^6,7, Celia Oreja-gueva⁸, Jacqueline Palace⁹, Sean J. Pittock¹⁰, Murat Terzi¹¹, Natalia Totolyan¹², Shanthi Viswanathan¹³, Kai-chen Wang^14,15, Amy Pace¹⁶, Marcus Yountz¹⁶, Larisa Miller¹⁶, Imran Tanvir¹⁶, Róisín Armstrong¹⁶, Dean M. Wingerchuk¹⁰ (1.Tohoku Medical and Pharmaceutical University, Japan, 2.Tohoku University, 3.Fukushima Medical University, 4.Technical University of Munich, 5.Research Institute and Hospital, Goyang, 6.Johns Hopkins University, 7.Massachusetts General Hospital, 8.Hospital Universitario Clínico San Carlos, 9.John Radcliffe Hospital, 10.Mayo Clinic, 11.Ondokuz Mayis University, 12.First Pavlov State Medical University of St Petersburg, 13.Kuala Lumpur Hospital, 14.Cheng-Hsin General Hospital, 15.National Yang Ming University, 16.Alexion Pharmaceuticals)

^○Hitoshi Warita¹, Masaaki Kato¹, Ryuta Asada², Atsuko Yamashita³, Hayata Hayata³, Kiichi Adachi³, Masashi Aoki¹ (1.Department of Neurology, Tohoku University Hospital, Japan, 2.Innovative and Clinical Research Promotion Center, Gifu University Hospital, 3.Kringle Pharma)

^○Shinichi Takahashi^1,2, Satoru Morimoto², Kensuke Okada³, Yugaku Daté³, Daisuke Ito³, Jin Nakahara³, Hideyuki Okano² (1.Department of Neurology and Stroke, Saitama Medical University International Medical Center, Japan, 2.Department of Physiology, Keio University School of Medicine, Japan, 3.Department of Neurology, Keio University School of Medicine)

^○Krishnan Ramanathan¹, Stephen L. Hauser², Amit Bar-or³, Jeffrey Cohen⁴, Giancarlo Comi⁵, Jorge Correale⁶, Patricia K. Coyle⁷, Anne H. Cross⁸, Jérôme De. Seze⁹, Xavier Montalban Et Al.¹⁰ (1.Novartis Pharma AG, Switzerland, 2.Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, 3.Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, 4.Neurological Institute, Cleveland Clinic, 5.University Vita-Salute San Raffaele, 6.Institute for Neurological Research Dr. Raul Carrea, 7.Stony Brook University, 8.Washington University School of Medicine, 9.University Hospital of Strasbourg, 10.St Michael's Hospital, University of Toronto)

^○Jerome De Seze¹, Brian G. Weinshenker², Yusuke Terada³, Yuichi Kawata³, Athos Gianella-borradori⁴, H.-christian Von Büdingen⁵, Gaelle Klingelschmitt⁵, Anthony Traboulsee⁶, Takashi Yamamura⁷ (1.Hôpital de Hautepierre, France, 2.Mayo Clinic, 3.Chugai Pharmaceutical Co., Ltd, Tokyo, 4.Chugai Pharma USA LLC, 5.F. Hoffmann-La Roche Ltd, 6.University of British Columbia, 7.National Center of Neurology and Psychiatry)